SocGen Starts GSK, NVS, SNY at Buy, AZN at Hold

An analyst at SocGen initiated coverage on several European big name pharma companies Thursday morning:

• GlaxoSmithKline (NYSE: GSK) with a Buy rating
  
• Novartis (NYSE: NVS) with a Buy rating
  
• Sanofi (NYSE: SNY) with a Buy rating
  
• AstraZeneca (NYSE: AZN) with a Hold rating

Check out our Ratings Insider portal to get the most comprehensive and up-to-date analyst coverage on the Street.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Needham Starts Faeth Therapeutics (FTH) at Buy
• Evercore ISI Starts MongoDB (MDB) at Outperform
• Truist Securities Starts Matthews International (MATW) at Hold, 'We see risk/reward as more balanced'